Stuart J. Schnitt, M.D. is an internationally recognized expert in breast pathology. A native of Brooklyn, NY, Dr. Schnitt received his undergraduate (B.S.) degree in 1975 from Brooklyn College of the City University of New York where he graduated summa cum laude, with honors in Biology. He subsequently received his M.D. degree from Albany Medical College in Albany, NY in 1979. Following medical school, he did an internship and residency in Anatomic and Clinical Pathology at Beth Israel Hospital in Boston (1979-1983) followed by a fellowship in surgical pathology, also at Beth Israel Hospital (1983-1984). He then joined the pathology faculty at Beth Israel Hospital in 1984 and has spent his entire career at Beth Israel Hospital/Beth Israel Deaconess Medical Center and Harvard Medical School. He is currently the Director of the Division of Anatomic Pathology at Beth Israel Deaconess Medical Center, a consultant in pathology at Brigham and Women's Hospital and the Dana Farber Cancer Institute, co-leader of the Dana Farber Harvard Cancer Center Breast Program, and a Professor of Pathology at Harvard Medical School.
Dr. Schnitt has published over 250 original articles, reviews, editorials, commentaries, and book chapters, primarily in the area of breast diseases, and he has lectured extensively throughout the United States, Canada, Latin America, Europe, Australia and Asia, including over 20 visiting professorships and named lectures. Along with Dr. Laura Collins, in 2009 he published a breast pathology textbook entitled "Biopsy Interpretation of the Breast" (which was recently translated to and published in Chinese). In addition, he is one of the editors of the upcoming 4th Edition of the "World Health Organization Classification of Tumours of the Breast". He currently serves on the editorial board of 13 journals. He has received the Arthur Purdy Stout Society of Surgical Pathologists Annual Prize (1999) and the Golden Microscope Award for Resident Teaching and Mentoring at Beth Israel Deaconess Medical Center (2003). He has been cited in multiple editions of "The Best Doctors in America" and "America's Top Doctors". His research interests have focused primarily on risk factors for local recurrence in patients with invasive breast cancer and ductal carcinoma in situ treated with breast conserving therapy, benign breast disease and breast cancer risk, and stromal-epithelial interactions in breast tumor progression.
Dr. Schnitt has been associated with the International Academy of Pathology and the United States and Canadian Academy of Pathology (USCAP) since he was a resident and he has attended every annual meeting since 1982. He has served as a moderator of numerous proferred paper sessions, a member of the Abstract Review Board, a director of five short courses, and a speaker in three long courses as well as in numerous Companion Society and Specialty Conference sessions. He served as co-director of the Long Course in Breast Pathology at the 2009 annual meeting, a director of the Academy's summer Diagnostic Pathology course from 2006-2010, and the first moderator of the Breast Evening Specialty Conference. In addition, he served terms on the Academy's Education Committee (1997-2001) and Council (2002-2005) as well as terms as Vice President (2008-2009), President-elect (2009-2010) and now President of the USCAP (2010-2011).
Dr. Schnitt states that he has been most fortunate to have trained and worked at an institution that has provided him with extraordinary opportunities as well as the chance to benefit from the wisdom and guidance of a number of exceptional pathologists who have been his teachers, mentors, and colleagues. Drs. Donald A. Antonioli, Richard B. Cohen, James L. Connolly, Harvey Goldman, and Seymour Rosen in particular have had a profound influence in shaping his career and his approach to the practice of pathology. In addition, Dr. Harold F. Dvorak and Dr. Jeffrey E. Saffitz have provided unwavering support and encouragement as his department chairmen. Dr. Schnitt is also grateful for having had the opportunity to work with excellent pathology residents and fellows over the years. He notes that his association with USCAP has afforded him the opportunity to work with and get to know many of the giants of late 20th century-early 21st century pathology and to forge many collegial relationships and friendships with pathologists from around the world. Finally, Dr. Schnitt believes that his election to the position of President of the USCAP is the pinnacle of his professional career and he is honored and humbled by the opportunity to serve in this position.